BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 33201251)

  • 1. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.
    Phan THG; Paliogiannis P; Nasrallah GK; Giordo R; Eid AH; Fois AG; Zinellu A; Mangoni AA; Pintus G
    Cell Mol Life Sci; 2021 Mar; 78(5):2031-2057. PubMed ID: 33201251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.
    Tanjore H; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L721-9. PubMed ID: 22287606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
    Ding Q; Luckhardt T; Hecker L; Zhou Y; Liu G; Antony VB; deAndrade J; Thannickal VJ
    Drugs; 2011 May; 71(8):981-1001. PubMed ID: 21668038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.
    Kropski JA; Lawson WE; Young LR; Blackwell TS
    Dis Model Mech; 2013 Jan; 6(1):9-17. PubMed ID: 23268535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy, Apoptosis, the Unfolded Protein Response, and Lung Function in Idiopathic Pulmonary Fibrosis.
    Sharma P; Alizadeh J; Juarez M; Samali A; Halayko AJ; Kenyon NJ; Ghavami S; Zeki AA
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
    J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cell Senescence Exacerbates Pulmonary Fibrosis Potentially Through Accelerated Endothelial to Mesenchymal Transition.
    Ramadhiani R; Ikeda K; Hirata KI; Emoto N
    Kobe J Med Sci; 2021 Nov; 67(3):E84-E91. PubMed ID: 35367994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
    Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
    Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis.
    Rubio K; Castillo-Negrete R; Barreto G
    Cell Signal; 2020 Jun; 70():109593. PubMed ID: 32135188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
    Hewlett JC; Kropski JA; Blackwell TS
    Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis.
    Gaikwad AV; Eapen MS; McAlinden KD; Chia C; Larby J; Myers S; Dey S; Haug G; Markos J; Glanville AR; Sohal SS
    Expert Rev Respir Med; 2020 Oct; 14(10):1027-1043. PubMed ID: 32659128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition.
    Cadena-Suárez AR; Hernández-Hernández HA; Alvarado-Vásquez N; Rangel-Escareño C; Sommer B; Negrete-García MC
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis.
    Mohanan A; Washimkar KR; Mugale MN
    Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119676. PubMed ID: 38242330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of idiopathic pulmonary fibrosis.
    Wolters PJ; Collard HR; Jones KD
    Annu Rev Pathol; 2014; 9():157-79. PubMed ID: 24050627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
    Merkt W; Bueno M; Mora AL; Lagares D
    Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis.
    Roque W; Cuevas-Mora K; Romero F
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress in pulmonary fibrosis.
    Burman A; Tanjore H; Blackwell TS
    Matrix Biol; 2018 Aug; 68-69():355-365. PubMed ID: 29567124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
    Chilosi M; Carloni A; Rossi A; Poletti V
    Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.